Wealth Insights Switzerland & Germany
Swift and insightful communications underpinned our business's success in the early 1800's, an advantage we used for the benefit of our clients. Now in the seventh generation of family control, this rich history of correspondence continues.
In the latest edition of our tri-annual Mosaique Insights publication, we look at the challenges we face as long-term investors during 2020's pandemic. We discuss the potential rebirth of the historically unloved pharmaceutical industry and bring insights on how "Big Tech" is investing in the rapidly evolving healthcare sector.
With updates from our Global Investment Strategist, CIO and Head of Investment & Portfolio Advisory, these videos are designed to bring you up-to-speed on our latest thoughts and analyses in a concise and comprehensive format. For clients only, please click here for our password-protected video-reviews.
At the core of Industry 4.0 lies interconnectivity, automation and artificial intelligence, which can lead to significantly reduced manufacturing costs. In our latest Instant Insights as well as a separate Q&A on talking robots, we discuss how this industry trend is set to change the global economy in profound ways.
With the clock counting down to voting day, in our interview with a Washington D.C.-based policy consultant as well as a New York-based fintech founder we capture some of the latest sentiment on the ground. As investors, we remain neutral on matters of politics and our interest in such affairs is narrow – specifically that of policy and its potential effect on the companies we hold in portfolios.
In this Investment Views we interview with Dr. Bruno Eschli, Investor Relations Officer at the Swiss pharmaceutical company Roche, we learn about the challenges of developing a vaccine for COVID-19, the pharmaceutical sector’s response to the crisis and how it could impact the industry’s reputation.